Revealing PAM as a Prognostic Biomarker and Therapeutic Target in Clear Cell Renal Cell Carcinoma. iCell, [S. l.], v. 2, n. 1, 2025. DOI: 10.71373/sb8yn590. Disponível em: https://www.icelljoural.com/index.php/iCell/article/view/10. Acesso em: 14 jun. 2025.